A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157Noah M. Hahn, Daniel M. Geynisman, Alex S. Baras et al.|Clinical Cancer Research|2016Cited by 72
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sitesRobert J. Allaway, Kerrington D. Smith, Dawn A. Fischer et al.|Oncotarget|2016Cited by 44